Find your next paid study

Washington University School of MedicineNCT06957431

~$150 – $3,000

Actual pay is set by the research site.

Multimodal Fetal and Placental Imaging and Biomarkers of Clinical Outcomes in Opioid Use Disorder

The goal of this observational study is to learn about the long term effects of prenatal opioid exposure. The main objectives are: * Long term goal: to improv…

Opioid Use DisorderSubstance-Related DisordersPregnancy Related+3 more

Senthil SadhasivamNCT06415994

~$10 – $1,125

Actual pay is set by the research site.

Phase 2

A Phase 2 Study of Bevacizumab, Erlotinib and Atezolizumab in Subjects With Advanced Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC) Associated or Sporadic Papillary Renal Cell Cancer

This phase II trial studies the effects of combination therapy with bevacizumab, erlotinib, and atezolizumab in treating patients with hereditary leiomyomatosi…

Hereditary Leiomyomatosis and Renal Cell CarcinomaPapillary Renal Cell CarcinomaRenal Cell Carcinoma+3 more

National Cancer Institute (NCI)NCT04981509

~$75 – $1,800

Actual pay is set by the research site.

Observational

Impact of Routine Electronic Patient-Reported Outcome (ePRO)Symptom Monitoring During Neoadjuvant Therapy in Patients withPancreatic Adenocarcinoma on Patient Experience and ClinicalOutcomes: A Prospective Pre-Post Implementation Study

To learn if routine symptom monitoring using questionnaires during chemotherapy and/or radiation therapy in patients with PDAC improves patient health-related …

ePROSymptom MonitoringNeoadjuvant Therapy+2 more

M.D. Anderson Cancer CenterNCT07829471

Actual pay is set by the research site.

Detection of Late Subclinical Cardiovascular Disease in Testicular Cancer Survivors Exposed to Cisplatin-based Chemotherapy and Bone Marrow Transplant

Late subclinical cardiovascular disease in testicular cancer survivors exposed to cisplatin-based chemotherapy and bone marrow transplant

Testicular CancerSurvivorshipASCVD+5 more

Indiana UniversityNCT05611307

Actual pay is set by the research site.

A Phase 1 Clinical Study to Investigate the Safety, Tolerability, and Preliminary Efficacy of HF158K1 in Participants With HER-2 Expressing Advanced Solid Tumors

HF158K1 is an investigational liposome form of doxorubicin hydrochloride, an anthracycline topoisomerase inhibitor, encapsulated by lipid membranes containing …

Solid Tumors, Adult

HighField Biopharmaceuticals CorporationNCT05861895

~$150 – $4,200

Actual pay is set by the research site.

Bone PainMetastatic Bone TumorBone Metastases in Subjects With Advanced Cancer

A Phase 1 Pharmacokinetic, Dosimetry, Safety, and Dose Optimization Study for a Single Dose of TLX090-Tx (153SmDOTMP) to Treat Metastatic Bone Pain

This is an open label, 2-part early phase study designed to evaluate the safety, pharmacokinetics, radiation dosimetry, and preliminary efficacy of TLX090-Tx i…

Telix Pharmaceuticals (Innovations) Pty LimitedNCT07197645

~$150 – $4,200

Actual pay is set by the research site.

Glioblastoma IDH (Isocitrate Dehydrogenase) WildtypeAstrocytoma, Grade III

A Phase 1/2 Open-label Study of Debio 0123 in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Debio 0123 in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma

The primary purpose of the Phase 1 (Dose Escalation) of this study is to identify the dose-limiting toxicities (DLTs) of Debio 0123 combined with temozolomide …

Debiopharm International SANCT05765812

~$150 – $4,500

Actual pay is set by the research site.

Radiofrequency Ablation for Management of Benign/Indeterminate Thyroid Nodules and Low Risk Papillary Thyroid Cancers

To track the outcomes of patients who have been treated with RFA and its long-term effectiveness, and to learn more about the quality of life of patients who h…

Low RiskPapillary Thyroid CancerRadiofrequency Ablation

M.D. Anderson Cancer CenterNCT07140757

Actual pay is set by the research site.

Advanced Hepatocellular Carcinoma (HCC)

An Open-Label Phase 2 Study of WGI-0301 Plus Lenvatinib in Patients With Advanced Hepatocellular Carcinoma as Second Line Therapy

This is a Phase II study being done at several hospitals without using a placebo. It will look at how safe and tolerable the drug WGI-0301 is when given togeth…

Zhejiang Haichang Biotech Co., Ltd.NCT07540832

~$150 – $4,200

Actual pay is set by the research site.

Observational

Aherence to Different Exercise Interventions

Only 50% of sedentary adults that start an exercise training program adhere to the program after 6 months. Exercise variety may improve adherence. The goal of …

Exercise Adherence

California Polytechnic State University-San Luis ObispoNCT06024577

Actual pay is set by the research site.

Observational

Data-driven Rural Interventions for Vitality and Endurance Pilot Study

The study aims to explore whether data driven, personalized wellness interventions-based on integrated genomic, clinical, behavioral, and functional data- are …

Healthy Adult